SynthesisArquivos de gastroenterologia2026
NUTRITION MANAGEMENT OF INFLAMMATORY BOWEL DISEASES: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S AND COLITIS (GEDIIB).
Synthesis in Arquivos de gastroenterologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInflammatory bowel diseases (IBD), specifically Crohn's disease and ulcerative colitis, are multifactorial conditions. Genetic and behavioral factors are associated with disease development and influence its progression. It is known that diet plays a role in this pathogenic process.
objectiveto position nutritional and dietary factors in the management of IBD.
methodsThis consensus was developed by nutritionists, gastroenterologists, and colorectal surgeons, members of GEDIIB (Brazilian Organization for Crohn's disease and colitis). A systematic review of the most recent evidence was conducted to support the recommendations/statements. All recommendations and statements were endorsed by stakeholders and IBD experts in a modified Delphi panel, achieving a consensus rate of at least 80%. RESULTS AND
conclusionthe recommendations were directed according to disease activity and severity. Nutritional screening and diagnosis, nutritional therapy in the active and remission phases of the disease, dietary management and exclusion diets, and supplementation were addressed. The consensus is targeted at nutritionists, general practitioners, gastroenterologists, and surgeons interested in managing adults with IBD. It supports decision-making by health insurance companies, regulatory agencies, and health institutional managers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.